SU11274

(3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylidene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide

FPYJSJDOHRDAMT-KQWNVCNZSA-N CHEBI:190974 6 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

6 Reactome pathways

Metabolite details

Identifier: FPYJSJDOHRDAMT-KQWNVCNZSA-N
InChI Key: FPYJSJDOHRDAMT-KQWNVCNZSA-N
IUPAC name: (3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylidene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide
Preferred name: SU11274
INN name: —
Synonym: SU-11274
ChEBI: CHEBI:190974

Reactome pathways

R-HSA-162582 - Signal Transduction
R-HSA-6806834 - Signaling by MET
R-HSA-6806942 - MET Receptor Activation
R-HSA-6807004 - Negative regulation of MET activity
R-HSA-9006934 - Signaling by Receptor Tyrosine Kinases
R-HSA-9734091 - Drug-mediated inhibition of MET activation

Observed in studies

Observed in differential profiles